Skip to Content

N 741 250 (Mexiletine 250 mg)

Pill imprint N 741 250 has been identified as Mexiletine hydrochloride 250 mg.

Mexiletine is used in the treatment of myotonia congenita; ventricular tachycardia; diabetic peripheral neuropathy; arrhythmia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Mexiletine 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mexiletine hydrochloride 250 mg N 741 250
Mexiletine hydrochloride 250 mg N 741 250
Mexiletine hydrochloride 250 mg N 741 250
Mexiletine hydrochloride
Imprint:
N 741 250
Strength:
250 mg
Color:
Green & Orange
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-8741
Inactive Ingredients:
silicon dioxide
magnesium stearate
corn starch
FD&C Yellow No. 6
gelatin
titanium dioxide
D&C Yellow No. 10
FD&C Blue No. 1
ammonia
ferrosoferric oxide
alcohol
FD&C Blue No. 2
FD&C Red No. 40
isopropyl alcohol
butyl alcohol
propylene glycol
shellac
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
42291-0626 AvKare, Inc.
55045-3635 Dispensing Solutions Inc. (repackager)
49999-0917 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide